Jan 4, 2021 Roth Capital Partners acted as Co-Manager for Harpoon Therapeutics, Inc. (Nasdaq: HARP) in its $115 Million Follow-On Roth Capital Partners
Dec 23, 2020 Roth Capital Partners acted as Co-Manager & Placement Agent for Cellectar Biosciences, Inc. (NASDAQ: CLRB) in its $24.5 Million Follow-On & concurrent $20.5 Million Private Placement Roth Capital Partners
Dec 23, 2020 Roth Capital Partners acted as Sole Book-Running Manager for Asure Software, Inc. (NASDAQ: ASUR) in its $18.9 Million Follow-On Roth Capital Partners
Dec 10, 2020 Roth Capital Partners acts as Sole Book-Running Manager for Vivos Therapeutics, Inc. (VVOS) in its $24.2 Million IPO Roth Capital Partners
Dec 10, 2020 Roth Capital Partners acts as Joint Book-Running Manager for Pixelworks, Inc. (Nasdaq: PXLW) in its $13.8 Million Follow-On Roth Capital Partners
Dec 10, 2020 Roth Capital Partners acts as Co-Manager for LivePerson, Inc. (NASDAQ: LPSN) in its $517.5 Million Convertible Senior Notes Offering Roth Capital Partners
Dec 9, 2020 Roth Capital Partners acted as Joint Book-Running Manager for Delcath Systems, Inc. (Nasdaq: DCTH) in its US$22.2 Million Follow-On Roth Capital Partners
Dec 8, 2020 Roth Capital Partners acted as Co-Manager for Atara Biotherapeutics, Inc. (Nasdaq: ATRA) in its $175 Million Follow-On Roth Capital Partners
